Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
BJU International
|
June 26, 2003
Diagnostic accuracy of flow rate testing in urology
H R H Patel, F Garcia-Montes, N Christopher, et al.
The Journal of Urology
|
November 13, 2004
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia
V Watson, M Ryan, C T Brown, et al.
The Journal of Urology
|
May 19, 2007
Re: Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. A. Villers, P. Puech, D. Mouton, X. Leroy, C. Ballereau and L. Lemaitre, J Urol 2006; 176: 2432-2437
H U Ahmed, J Calleary, M Arya, et al.
The British Journal of Radiology
|
January 19, 2012
Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent disease
S Punwani, M Emberton, M Walkden, et al.
Prostate Cancer and Prostatic Diseases
|
March 14, 2007
Point-of-care PSA testing: an evaluation of PSAwatch
O Karim, A Rao, M Emberton, et al.
BJU International
|
March 5, 2003
The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?
C T Brown, E O'Flynn, J Van Der Meulen, et al.
Voprosy Onkologii
|
October 26, 2010
[Significance of the number of biopsy specimens from the prostate gland for adequate clinical appraisal of neoplasia]
V V Iremashvili, A K Chepurov, M Emberton, et al.
World Journal of Urology
|
October 15, 2013
Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer
A Kanthabalan, M Arya, S Punwani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 3, 2020
What to expect from a non-suspicious prostate MRI? A review
G Fiard, J M Norris, T A Nguyen, et al.
The Journal of Urology
|
January 13, 2006
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily
R Hartung, H Matzkin, A Alcaraz, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
BJU International
|
June 26, 2003
Diagnostic accuracy of flow rate testing in urology
H R H Patel, F Garcia-Montes, N Christopher, et al.
The Journal of Urology
|
November 13, 2004
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia
V Watson, M Ryan, C T Brown, et al.
The Journal of Urology
|
May 19, 2007
Re: Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. A. Villers, P. Puech, D. Mouton, X. Leroy, C. Ballereau and L. Lemaitre, J Urol 2006; 176: 2432-2437
H U Ahmed, J Calleary, M Arya, et al.
The British Journal of Radiology
|
January 19, 2012
Prostatic cancer surveillance following whole-gland high-intensity focused ultrasound: comparison of MRI and prostate-specific antigen for detection of residual or recurrent disease
S Punwani, M Emberton, M Walkden, et al.
Prostate Cancer and Prostatic Diseases
|
March 14, 2007
Point-of-care PSA testing: an evaluation of PSAwatch
O Karim, A Rao, M Emberton, et al.
BJU International
|
March 5, 2003
The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?
C T Brown, E O'Flynn, J Van Der Meulen, et al.
Voprosy Onkologii
|
October 26, 2010
[Significance of the number of biopsy specimens from the prostate gland for adequate clinical appraisal of neoplasia]
V V Iremashvili, A K Chepurov, M Emberton, et al.
World Journal of Urology
|
October 15, 2013
Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer
A Kanthabalan, M Arya, S Punwani, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 3, 2020
What to expect from a non-suspicious prostate MRI? A review
G Fiard, J M Norris, T A Nguyen, et al.
The Journal of Urology
|
January 13, 2006
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily
R Hartung, H Matzkin, A Alcaraz, et al.
Page
of 11